Ecosystem and Business Model
EXOT Ecosystem Participants: Roles and Incentives
The EXOT ecosystem is not controlled by any single institution or centralized entity. Instead, it is designed as a “decentralized biotech value-creation system” in which all participants—biotech companies, investors, experts, and the community—contribute according to their unique expertise and roles, and receive both economic and non-economic rewards in a fair and balanced manner.
This ecosystem is built on a next-generation DeSci-RWA hybrid model that directly connects real-world assets (equity in biotech companies) with an on-chain token economy. Through this structure, each participant complements the others’ roles, collectively increasing the success probability of biotech projects and maximizing the overall value of the ecosystem.
Stakeholder
Role
Incentives
Bio Company
Develop innovative drug technologies, core value creators for the ecosystem
Stable capital funding to overcome the 'Valley of Death', global community feedback and support, business development assistance via the EXOT network
Investor
Supply capital to the platform, share risk and reward from individual company growth
Investment opportunities in historically inaccessible promising early-stage biotech, high Capital Gain, flexibility in capital withdrawal via liquid tokenized equity
EXOT Holder / DAO Member
Hold and stake EXOT tokens, participate in platform governance (e.g., investment selection, fee policy)
Staking Rewards from platform revenue, potential appreciation of EXOT token value based on long-term ecosystem growth
Scientific Advisory Board (SAB)
Objectively verify the technical validity of investment candidates based on top-tier scientific expertise, compile due diligence reports
Professional Fees for report preparation, prestige and reputation from successful commercialization, (some) success fees in the form of stock options
EXOT Foundation
Support the smooth operation of the ecosystem (initial protocol development, legal/administrative support, partnership building). Role gradually transitions to the DAO.
Focus on the sustainable growth and mission attainment of the protocol (Non-profit)
Business Model: A Sustainable Revenue Generation Structure
The EXOT platform has designed a diversified revenue model to continuously enhance the growth and value of the ecosystem. All revenue, excluding the Foundation's operating expenses, is allocated to the DAO Treasury and reinvested for the development of the ecosystem.
Revenue Model
Description
Rate/Ratio/cost
Feature
Platform Fee
Charged to bio companies upon successful funding
5–7% of total funding amount
Competitive with traditional IB fees; covers deal sourcing, due diligence, and support
Carried Interest
Charged on returns exceeding the principal when portfolio companies exit (Exit)
15–20% of the excess return
Lower than traditional VC fees (20–25%), core income source for the DAO Treasury
DAO Participation Cost
EXOT tokens paid or burned to participate in DAO governance voting
Minimum 10 EXOT
(scales with amount staked)
Encourages active participation and provides constant cash flow to the ecosystem, reduces token supply—which creates upward pressure on value—and grants greater voting power to participants who contribute more tokens.
Data Service
Subscription-based sale of anonymized clinical and investment data
-
Potential long-term core revenue stream (to Pharma, research institutions, asset managers)
DAO Treasury
EXOT Token Exchange, Profit Distribution, and Rights Structure
(Investment Company ↔ Bio Company)
The investment company and the EXOT platform exchange the investment amount and the equivalent value of EXOT tokens (with an ultra-long-term lock-up).
The EXOT tokens received by the investment company are deposited into the DAO Treasury, which functions as an institutional investor with greater governance influence than general participants.
The EXOT platform then transfers the investment funds received from the investment company to the bio company as project capital.
When the bio company’s project begins to generate results and profits, the DAO Treasury (representing the investment company) holds 100% of the project rights and receives approximately 80% of the profits.
The EXOT platform receives approximately 20% of the profits, based on the performance of the bio company’s project, and does not hold any project rights.
For EXOT tokens held by institutional investors, a separate initial vesting structure may be defined according to mutually agreed governance rules.
DAO Treasury Staking Pool Structure
Both institutional and retail investors can stake EXOT tokens in the staking pool of each bio company.
The staking pool distributes EXOT rewards (interest) to participants who stake their tokens.
Institutional investors and general investors are classified based on the size of their investment.
The staking interest rate can be set differently for each bio company receiving investment.
Last updated